These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 26926467)

  • 1. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in cardiovascular disease: an introduction for clinicians.
    Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
    Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
    Huang Y; Li J
    J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
    Wang J; Liew OW; Richards AM; Chen YT
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
    Wronska A
    J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: roles in cardiovascular development and disease.
    Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
    Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MicroRNAs: what cardiologists should know about them?].
    Mericskay M
    Presse Med; 2015; 44(7-8):761-71. PubMed ID: 26163829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
    Pan ZW; Lu YJ; Yang BF
    Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.